Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Determining How the Mechanosensitive GPR56 Controls Chondrogenic Potential in Craniofacial Cartilages and Cranial Sutures
FY 2025-26
Summary
Non-melanoma skin cancer is the most common human cancer, most often occurring on the nose. Standard treatment is surgical removal of the cancerous tissue, often resulting in removal of a large portion of the nasal lobule. Nasal reconstruction requires isolation of cartilage from elsewhere from the body that can be used as a cartilage graft. This is painful and associated with additional risks. Tissue engineering is a safe and effective alternative, but requires establishment of robust protocols for cell isolation and graft production. Our research team identified G protein-coupled receptor 56 (GPR56) as a marker expressed on chondrocyte precursor cells with the ability to form high-quality engineered cartilage. GPR56 is a mechanosensitive transmembrane protein that in many contexts controls cell differentiation, such as that of insulin producing beta-progenitor cells and cerebral cortex development. In nasal cartilage, GPR56 is also expressed in progenitor cells. We hypothesize that GPR56 controls nasal cartilage properties by influencing cartilage progenitor cells in response to mechanical stimuli. This study will use state-of-the art imaging, as well as molecular and cellular approaches to undertake a detailed analysis of GPR56 in craniofacial tissues and provide insights into the results of loss of GPR56, with a focus on exploring how GPR56 is associated with the development of high-quality cartilage.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573120
Name
Borden Brogan M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining How the Mechanosensitive GPR56 Controls Chondrogenic Potential in Craniofacial Cartilages and Cranial Sutures
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cartilage Differentiation; Chondrocytes; Cranial Sutures; Craniofacial Deformation; G Protein-Coupled Receptor 56; High-Quality Engineered Cartilage; Nasal Cartilage; Nasal Reconstruction; Progenitor Cells; Tissue Engineering
Abstract
Non-melanoma skin cancer is the most common human cancer, most often occurring on the nose. Standard treatment is surgical removal of the cancerous tissue, often resulting in removal of a large portion of the nasal lobule. Nasal reconstruction requires isolation of cartilage from elsewhere from the body that can be used as a cartilage graft. This is painful and associated with additional risks. Tissue engineering is a safe and effective alternative, but requires establishment of robust protocols for cell isolation and graft production. Our research team identified G protein-coupled receptor 56 (GPR56) as a marker expressed on chondrocyte precursor cells with the ability to form high-quality engineered cartilage. GPR56 is a mechanosensitive transmembrane protein that in many contexts controls cell differentiation, such as that of insulin producing beta-progenitor cells and cerebral cortex development. In nasal cartilage, GPR56 is also expressed in progenitor cells. We hypothesize that GPR56 controls nasal cartilage properties by influencing cartilage progenitor cells in response to mechanical stimuli. This study will use state-of-the art imaging, as well as molecular and cellular approaches to undertake a detailed analysis of GPR56 in craniofacial tissues and provide insights into the results of loss of GPR56, with a focus on exploring how GPR56 is associated with the development of high-quality cartilage.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Borden, Brogan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~